KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Interest Coverage Ratio (2023 - 2025)

Travere Therapeutics' Interest Coverage Ratio history spans 7 years, with the latest figure at 14.74 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 31.2% year-over-year to 14.74; the TTM value through Dec 2025 reached 5.87, up 79.69%, while the annual FY2025 figure was 5.87, 79.69% up from the prior year.
  • Interest Coverage Ratio reached 14.74 in Q4 2025 per TVTX's latest filing, down from 9.06 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 9.06 in Q3 2025 to a low of 49.73 in Q1 2024.
  • Average Interest Coverage Ratio over 3 years is 22.15, with a median of 21.42 recorded in 2024.
  • The largest YoY upside for Interest Coverage Ratio was 144.82% in 2025 against a maximum downside of 31.2% in 2025.
  • A 3-year view of Interest Coverage Ratio shows it stood at 33.25 in 2023, then skyrocketed by 35.57% to 21.42 in 2024, then surged by 31.2% to 14.74 in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Interest Coverage Ratio are 14.74 (Q4 2025), 9.06 (Q3 2025), and 4.44 (Q2 2025).